Correlation Between Aerovate Therapeutics and 049560AW5

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and 049560AW5 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and 049560AW5 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and ATO 285 15 FEB 52, you can compare the effects of market volatilities on Aerovate Therapeutics and 049560AW5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 049560AW5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 049560AW5.

Diversification Opportunities for Aerovate Therapeutics and 049560AW5

-0.39

Correlation Coefficient

Aerovate Therapeutics  049560AW5

Very good diversification

The 3 months correlation between Aerovate and 049560AW5 is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and ATO 285 15 FEB 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATO 285 15 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 049560AW5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATO 285 15 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 049560AW5 go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and 049560AW5

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the 049560AW5. In addition to that, Aerovate Therapeutics is 3.52 times more volatile than ATO 285 15 FEB 52. It trades about 0.0 of its total potential returns per unit of risk. ATO 285 15 FEB 52 is currently generating about 0.03 per unit of volatility. If you would invest  6,661  in ATO 285 15 FEB 52 on September 21, 2024 and sell it today you would earn a total of  714.00  from holding ATO 285 15 FEB 52 or generate 10.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	49.29%
Values	Daily Returns

Aerovate Therapeutics  vs.  ATO 285 15 FEB 52

Aerovate Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

ATO 285 15

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ATO 285 15 FEB 52 are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 049560AW5 sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and 049560AW5

The main advantage of trading using opposite Aerovate Therapeutics and 049560AW5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 049560AW5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 049560AW5 will offset losses from the drop in 049560AW5's long position.

The idea behind Aerovate Therapeutics and ATO 285 15 FEB 52 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.